Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis

Objective: Despite advancements in treatment, multiple myeloma (MM) remains a challenging hematologic malignancy. It is crucial to stratify risk and perform prognostic assessment with various markers, including the expression of cluster of differentiation 56 (CD56) and cluster of differentiation 117...

Full description

Saved in:
Bibliographic Details
Main Authors: Hakan Keski, Selim Merdan, Itır Ebru Zemheri
Format: Article
Language:English
Published: Galenos Publishing House 2024-12-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-14306
Tags: Add Tag
No Tags, Be the first to tag this record!